Pacific Biosciences of California Inc.
PACB | NASDAQ
$1.36
-$0.01 (-0.73%)
At close: Sep 21, 2026, 4:00 PM ET
$1.37
+$0.01 (+0.74%)
Pre-market:
Sep 22, 2026, 6:48 AM ET
Market Data
Market Cap $425.52M
Enterprise Value $1.07B
Beta 2.31
Average Volume 6.49M
Shares Outstanding (Diluted) 310.66M
Shares Change YoY 3.5%
Institutional Ownership 61.54%
Exchange NASDAQ
ISIN US69404D1081
Price Performance
Price Change 1M 0.7%
Price Change 3M 3.8%
Price Change 6M -2.2%
Price Change YTD -26.1%
Price Change 1Y 5.4%
Price Change 3Y -84.8%
Price Change 5Y -94.7%
1M CAGR (ann.) 17.1%
1Y CAGR (ann.) 11.4%
5Y CAGR (ann.) -46.0%
All-Time CAGR -14.5%
Valuation
PE Ratio -3.16
Forward PE N/A
PEG Ratio -0.05
Forward PEG 2.73
PS Ratio 2.65
Forward PS 2.30
PB Ratio -12.72
P/FCF Ratio -2.47
P/Adj. FCF Ratio -2.17
P/OCF Ratio -2.62
EV/Sales 6.70
EV/EBIT -8.43
EV/EBITDA -9.40
EV/FCF -6.24
Earnings Yield -31.6%
FCF Yield -40.5%
Adj. FCF Yield -46.0%
Financial Health
Net Debt $645.12M
Total Debt $706.13M
Cash & Short-Term Investments $61M
Total Assets $751.85M
Current Ratio 4.92
Quick Ratio 4.03
Debt / Equity Ratio -21.26
Debt / EBITDA -6.22
Debt / FCF -4.13
OCF / Debt -0.23
Interest Coverage -42.23
Altman Z-Score -4.71
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 36.0%
Operating Profit Margin -102.0%
EBITDA Margin -68.5%
Net Profit Margin -82.5%
FCF Margin -107.5%
Adj. FCF Margin -122.1%
SBC / Revenue 14.6%
SBC Impact (per share) -13.6%
Returns
Return on Assets -17.5%
Return on Equity -4961.7%
Return on Invested Capital -23.8%
Return on Capital Employed -23.8%
Return on Tangible Assets -31.2%
Historical Growth (CAGR)
Revenue CAGR 3Y 2.9%
Revenue CAGR 5Y 8.5%
Revenue CAGR 10Y 5.9%
EPS CAGR 3Y 43.1%
EPS CAGR 5Y 4.6%
EPS CAGR 10Y -6.8%
FCF CAGR 3Y 22.9%
FCF CAGR 5Y 10.5%
FCF CAGR 10Y -15.1%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 18
EPS Growth Next 3Y 13.2%
Revenue Growth Next 3Y 15.0%
Earnings Date Nov 2, 2026
EPS Estimate (next Q) -$0.13
EPS Growth Est (next Q) 5.0%
Revenue Est (next Q) $43.82M
Revenue Growth Est (next Q) 14.0%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $1.18
Price Target Upside -13.2%
Cash Flow
Operating Cash Flow $-162.74M
Free Cash Flow $-171.16M
Adj. Free Cash Flow $-194.47M
FCF Per Share -$0.55
OCF Per Share -$0.52
OCF/S Ratio -102.2%
Income Statement
Revenue $159.27M
Gross Profit $57.3M
Operating Income $-162.54M
EBITDA $-113.6M
Net Income $-131.39M
EPS (Diluted) -$0.43
Revenue / Employee $328.39K
Profit / Employee $-270.9K
Employees 485
Add to Watchlist
Select watchlists to add or remove PACB